Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greg International Pharmaceuticals, commonly known as Greg Pharma, is an Egyptian pharmaceutical company that specializes in the development, manufacturing, and distribution of generic medicines and nutritional supplements. Headquartered in Giza, the company focuses on providing high-quality and affordable healthcare solutions to the Middle East and North Africa (MENA) region. Its product portfolio is diverse, covering therapeutic areas such as orthopedics, gastroenterology, cardiovascular health, and immunology. Greg Pharma is particularly recognized for its line of essential vitamins and minerals, including products like Greg-Z and Greg-D3, which address common nutritional deficiencies. The company operates manufacturing facilities that comply with regional regulatory standards, ensuring the safety and efficacy of its oral solid and liquid formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greg Pharma.